Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Testosterone may slow down wound healing and increase inflammation.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Burn reconstruction improves with new techniques, materials, and tissue engineering.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Finasteride and minoxidil work best together for hair loss.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

HIV can cause unusual and severe skin problems that are hard to treat.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Flutamide reduces hair growth better but has more side effects.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.